Log | Progress In Mind

Log Type	Authored on	Log Message	Log Node	Authored by
Newsletter opened	Wed, 10/12/2022 - 17:22	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 17:22	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 17:22	Opened		Gäst
Newsletter clicked	Tue, 11/08/2022 - 21:12	Clicked https://brazil.progress.im/pt-br/content/como-os-pacientes-respondem-ao-mudar-de-um-anticorpo-monoclonal-anti-cgrp-para-outro		Gäst
Newsletter opened	Wed, 10/12/2022 - 17:22	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 17:22	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 17:22	Opened		Gäst
User created	Wed, 10/12/2022 - 17:22	User created		Gäst
Newsletter opened	Wed, 10/12/2022 - 17:22	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 17:22	Opened		Gäst
Newsletter clicked	Tue, 11/08/2022 - 21:12	Clicked https://brazil.progress.im/pt-br/content/inova%C3%A7%C3%A3o-e-tratamentos-personalizados-geram-melhores-resultados-na-depress%C3%A3o	Psiquiatria e Neurologia: Fique por dentro em 5 minutos!	Gäst
Newsletter opened	Wed, 10/12/2022 - 17:22	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 17:22	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 17:22	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 17:22	Opened		Gäst
Newsletter clicked	Tue, 11/08/2022 - 21:12	Clicked https://brazil.progress.im/pt-br/content/novos-conhecimentos-sobre-fatores-de-risco-gen%C3%A9ticos-e-metas-de-interven%C3%A7%C3%A3o-na-doen%C3%A7a-de		Gäst
Newsletter opened	Wed, 10/12/2022 - 17:22	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 17:22	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 17:22	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 17:22	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 17:22	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 17:22	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 17:22	Opened	[Esquizofrenia] Melhorando a adesão ao tratamento em pacientes em fase inicial	Gäst
Newsletter opened	Wed, 10/12/2022 - 17:22	Opened	[Esquizofrenia] Melhorando a adesão ao tratamento em pacientes em fase inicial	Gäst
Newsletter opened	Wed, 10/12/2022 - 17:22	Opened		Gäst

Log Type	Authored on	Log Message	Log Node	Authored by
Newsletter opened	Wed, 10/12/2022 - 17:22	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 17:22	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 17:22	Opened		Gäst
Newsletter clicked	Tue, 11/08/2022 - 21:12	Clicked https://brazil.progress.im/pt-br/content/como-os-pacientes-respondem-ao-mudar-de-um-anticorpo-monoclonal-anti-cgrp-para-outro		Gäst
Newsletter opened	Wed, 10/12/2022 - 17:22	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 17:22	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 17:22	Opened		Gäst
User created	Wed, 10/12/2022 - 17:22	User created		Gäst
Newsletter opened	Wed, 10/12/2022 - 17:22	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 17:22	Opened		Gäst
Newsletter clicked	Tue, 11/08/2022 - 21:12	Clicked https://brazil.progress.im/pt-br/content/inova%C3%A7%C3%A3o-e-tratamentos-personalizados-geram-melhores-resultados-na-depress%C3%A3o	Psiquiatria e Neurologia: Fique por dentro em 5 minutos!	Gäst
Newsletter opened	Wed, 10/12/2022 - 17:22	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 17:22	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 17:22	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 17:22	Opened		Gäst
Newsletter clicked	Tue, 11/08/2022 - 21:12	Clicked https://brazil.progress.im/pt-br/content/novos-conhecimentos-sobre-fatores-de-risco-gen%C3%A9ticos-e-metas-de-interven%C3%A7%C3%A3o-na-doen%C3%A7a-de		Gäst
Newsletter opened	Wed, 10/12/2022 - 17:22	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 17:22	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 17:22	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 17:22	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 17:22	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 17:22	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 17:22	Opened	[Esquizofrenia] Melhorando a adesão ao tratamento em pacientes em fase inicial	Gäst
Newsletter opened	Wed, 10/12/2022 - 17:22	Opened	[Esquizofrenia] Melhorando a adesão ao tratamento em pacientes em fase inicial	Gäst
Newsletter opened	Wed, 10/12/2022 - 17:22	Opened		Gäst

Patrocinado por

Progress in Mind Brazil

INSCRIÇÃO NEWSLETTER